Article Text
Abstract
The carbon emissions of global healthcare activities make up 4%–5% of total world emissions, with the majority coming from industrialised countries. The solution to healthcare carbon reduction in these countries, ostensibly, would be preventive healthcare, which is less resource intensive than corrective healthcare in itself and, as a double benefit, reduces carbon by preventing diseases which may require higher healthcare carbon to treat. This leads to a paradox: preventive healthcare is designed to give humans longer, healthier lives. But, by extending life spans, the carbon emissions of a person increase both over a lifetime and in the medical industry overall. At the same time, the need for higher carbon end-of-life care does not disappear, particularly in resource intensive countries. This article will first identify sources of healthcare carbon, focusing on the industrialised world, and explain various efforts towards healthcare carbon reduction, which include preventive healthcare. Second, it will develop the ‘paradox of prevention’—that preventive healthcare may save healthcare carbon by proximally reducing the need for medical treatments, but also, paradoxically, result in more healthcare carbon both in an individual’s life and in the medical industry. The third section will offer ethical principles for approaching the paradox of prevention. The conclusion will emphasise the need for institutional approaches to healthcare carbon reduction in the industrialised world, which will relieve some of the tensions of healthcare industry decarbonisation and individual healthcare carbon use.
- Environment
- Ethics
- Policy
- Public Policy
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Contributors The author wrote, researched, and edited the mss. The author is also the guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Environmental sustainability and the carbon emissions of pharmaceuticals
- Realist evaluation of the implementation and impact of the NHS carbon reduction strategy in the UK
- What would an environmentally sustainable reproductive technology industry look like?
- Priority setting and net zero healthcare: how much health can a tonne of carbon buy?
- Vital role of clinicians in reducing the NHS carbon footprint through smarter procurement decisions
- Reimagining research ethics to include environmental sustainability: a principled approach, including a case study of data-driven health research
- The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance
- Carbon footprint of industry-sponsored late-stage clinical trials
- Decarbonising healthcare in low and middle income countries: potential pathways to net zero emissions
- Making healthcare and health systems net zero